Current and historical daily PE Ratio for Hansoh Pharmaceutical Group Co Ltd (
HKSE:03692
) from 2019 to May 12 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hansoh Pharmaceutical Group stock (HKSE:03692) PE ratio as of May 12 2024 is 31.81.
More Details
Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) PE Ratio (TTM) Chart
Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Total 1203
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Hansoh Pharmaceutical Group PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-13 | 31.8 | 2024-03-05 | 24.1 |
| 2024-05-10 | 31.8 | 2024-03-04 | 25.6 |
| 2024-05-09 | 31.0 | 2024-03-01 | 23.9 |
| 2024-05-08 | 31.6 | 2024-02-29 | 24.3 |
| 2024-05-07 | 32.2 | 2024-02-28 | 23.4 |
| 2024-05-06 | 32.2 | 2024-02-27 | 23.4 |
| 2024-05-03 | 32.1 | 2024-02-26 | 23.1 |
| 2024-05-02 | 31.9 | 2024-02-23 | 23.4 |
| 2024-04-30 | 30.6 | 2024-02-22 | 23.8 |
| 2024-04-29 | 30.7 | 2024-02-21 | 23.6 |
| 2024-04-26 | 30.3 | 2024-02-20 | 23.3 |
| 2024-04-25 | 29.5 | 2024-02-19 | 23.2 |
| 2024-04-24 | 29.5 | 2024-02-16 | 23.7 |
| 2024-04-23 | 28.7 | 2024-02-15 | 22.8 |
| 2024-04-22 | 28.2 | 2024-02-14 | 22.6 |
| 2024-04-19 | 27.0 | 2024-02-09 | 21.4 |
| 2024-04-18 | 27.5 | 2024-02-08 | 22.4 |
| 2024-04-17 | 27.7 | 2024-02-07 | 22.2 |
| 2024-04-16 | 27.7 | 2024-02-06 | 22.5 |
| 2024-04-15 | 28.5 | 2024-02-05 | 20.5 |
| 2024-04-12 | 28.2 | 2024-02-02 | 20.0 |
| 2024-04-11 | 28.4 | 2024-02-01 | 20.8 |
| 2024-04-10 | 28.2 | 2024-01-31 | 20.6 |
| 2024-04-09 | 27.7 | 2024-01-30 | 21.4 |
| 2024-04-08 | 27.1 | 2024-01-29 | 21.2 |
| 2024-04-05 | 27.9 | 2024-01-26 | 21.1 |
| 2024-04-03 | 27.4 | 2024-01-25 | 21.9 |
| 2024-04-02 | 27.9 | 2024-01-24 | 21.5 |
| 2024-03-28 | 27.2 | 2024-01-23 | 21.1 |
| 2024-03-27 | 27.2 | 2024-01-22 | 20.3 |
| 2024-03-26 | 26.1 | 2024-01-19 | 21.7 |
| 2024-03-25 | 25.9 | 2024-01-18 | 22.6 |
| 2024-03-22 | 25.8 | 2024-01-17 | 22.2 |
| 2024-03-21 | 26.1 | 2024-01-16 | 23.5 |
| 2024-03-20 | 26.3 | 2024-01-15 | 23.4 |
| 2024-03-19 | 25.8 | 2024-01-12 | 23.9 |
| 2024-03-18 | 26.6 | 2024-01-11 | 23.9 |
| 2024-03-15 | 26.9 | 2024-01-10 | 24.5 |
| 2024-03-14 | 26.4 | 2024-01-09 | 23.9 |
| 2024-03-13 | 26.9 | 2024-01-08 | 23.7 |
| 2024-03-12 | 26.3 | 2024-01-05 | 24.5 |
| 2024-03-11 | 24.7 | 2024-01-04 | 26.2 |
| 2024-03-08 | 24.6 | 2024-01-03 | 26.5 |
| 2024-03-07 | 23.7 | 2024-01-02 | 26.6 |
| 2024-03-06 | 23.9 | 2023-12-29 | 27.7 |
Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Hansoh Pharmaceutical Group Co Ltd
ISIN : KYG549581067
Compare
Compare
Traded in other countries / regions
03692.Hong Kong3KY.GermanyHNSPF.USA IPO Date
2019-06-14Description
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers